HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Thiemermann Selected Research

tempol

5/2004Tempol, an intracelullar free radical scavenger, reduces liver injury in hepatic ischemia-reperfusion in the rat.
1/2001Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat.
10/2000Tempol, a membrane-permeable radical scavenger, reduces dinitrobenzene sulfonic acid-induced colitis.
9/2000Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury.
8/2000Tempol, a membrane-permeable radical scavenger, reduces oxidant stress-mediated renal dysfunction and injury in the rat.
8/2000Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of splanchnic artery occlusion and reperfusion.
6/2000Membrane-permeable radical scavenger, tempol, reduces multiple organ injury in a rodent model of gram-positive shock.
2/2000Effects of tempol, a membrane-permeable radical scavenger, in a rodent model of carrageenan-induced pleurisy.
2/2000Beneficial effects of tempol, a membrane-permeable radical scavenger, in a rodent model of collagen-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Thiemermann Research Topics

Disease

10Inflammation (Inflammations)
01/2012 - 02/2000
10Shock
12/2002 - 01/2000
9Reperfusion Injury
02/2010 - 04/2000
8Ischemia
02/2010 - 04/2000
6Lung Injury
10/2010 - 02/2000
5Necrosis
11/2006 - 09/2000
5Myocardial Infarction
08/2006 - 07/2000
5Multiple Organ Failure (MODS)
06/2002 - 06/2000
4Sepsis (Septicemia)
07/2017 - 07/2000
4Pleurisy (Pleuritis)
11/2006 - 02/2000
4Infarction (Infarctions)
01/2004 - 06/2000
3Hemorrhagic Shock
12/2002 - 01/2001
3Hemorrhage
12/2002 - 01/2001
3Hypotension (Low Blood Pressure)
08/2001 - 01/2000
3Colitis
04/2001 - 09/2000
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
04/2001 - 09/2000
3Experimental Arthritis
12/2000 - 02/2000
2Myocardial Ischemia (Ischemic Heart Diseases)
08/2006 - 06/2000
2Body Weight (Weight, Body)
02/2005 - 10/2000
2Peritonitis
06/2002 - 01/2001
2Weight Loss (Weight Reduction)
04/2001 - 09/2000
2Bacterial Infections (Bacterial Infection)
02/2001 - 02/2001
2Diarrhea
10/2000 - 09/2000
1Cardiomyopathies (Cardiomyopathy)
07/2017
1Insulin Resistance
12/2014
1Wounds and Injuries (Trauma)
01/2012
1Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2010
1Pneumonia (Pneumonitis)
10/2010

Drug/Important Bio-Agent (IBA)

9tempolIBA
05/2004 - 02/2000
7Reactive Oxygen Species (Oxygen Radicals)IBA
05/2004 - 02/2000
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2007 - 01/2000
5Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2010 - 01/2000
5EndotoxinsIBA
08/2006 - 01/2000
4CreatinineIBA
02/2010 - 04/2000
4Urea (Carbamide)FDA LinkGeneric
02/2010 - 04/2000
4NitritesIBA
02/2010 - 06/2000
43-nitrotyrosineIBA
07/2007 - 08/2000
4Peroxidase (Myeloperoxidase)IBA
07/2007 - 02/2000
4CarrageenanIBA
11/2006 - 02/2000
4Peptidoglycan (Murein)IBA
09/2001 - 06/2000
4Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
04/2001 - 06/2000
4Biological ProductsIBA
01/2001 - 02/2000
3Bleomycin (Blenoxane)FDA LinkGeneric
10/2010 - 02/2005
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2005 - 06/2001
3Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
02/2005 - 06/2000
3TransferasesIBA
05/2004 - 06/2000
3Tyrosine Kinase InhibitorsIBA
06/2002 - 07/2000
3CytokinesIBA
09/2001 - 07/2000
3CalpainIBA
06/2001 - 12/2000
3DinitrobenzenesIBA
04/2001 - 09/2000
3P-SelectinIBA
04/2001 - 06/2000
3acetylleucyl-leucyl-norleucinalIBA
04/2001 - 12/2000
2Glycogen Synthase (Synthase I)IBA
07/2007 - 11/2006
2Glycogen Synthase Kinase 3 betaIBA
07/2007 - 11/2006
24- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA
07/2007 - 11/2006
2NitratesIBA
11/2006 - 06/2000
2PPAR gammaIBA
02/2005 - 01/2004
2PPAR-gamma AgonistsIBA
02/2005 - 01/2004
2LigandsIBA
01/2004 - 07/2001
2Nitric Oxide Synthase (NO Synthase)IBA
12/2002 - 01/2000
2tyrphostin AG 126IBA
06/2002 - 09/2000
2ZymosanIBA
06/2002 - 01/2001
25-aminoisoquinolinoneIBA
10/2001 - 06/2000
2LipopolysaccharidesIBA
09/2001 - 08/2001
2lipoteichoic acidIBA
08/2001 - 06/2000
2Cysteine Proteases (Cysteine Protease)IBA
06/2001 - 01/2001
2Oxygen (Dioxygen)IBA
04/2001 - 04/2000
2Troponin T (Troponin T1)IBA
04/2001 - 06/2000
22,4-dinitrofluorobenzene sulfonic acidIBA
04/2001 - 09/2000
2Sulfonic AcidsIBA
10/2000 - 09/2000
2Ligases (Synthetase)IBA
09/2000 - 04/2000
2TyrphostinsIBA
09/2000 - 07/2000
2AG 127 (AG 126)IBA
09/2000 - 07/2000
2Poly Adenosine Diphosphate RiboseIBA
09/2000 - 04/2000
2Malondialdehyde (Propanedial)IBA
09/2000 - 02/2000
2Aspartate Aminotransferases (Aspartate Transaminase)IBA
08/2000 - 06/2000
1Glucose (Dextrose)FDA LinkGeneric
12/2014
1Peptides (Polypeptides)IBA
12/2014
1ErythropoietinFDA Link
12/2014
1LipidsIBA
12/2014
1AlarminsIBA
01/2012
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2010
1Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA
10/2010
1(4- (((2- (3- fluoro- 4- (trifluoromethyl)phenyl)- 4- methyl- 1,3- thiazol- 5- yl)methyl)sulfanyl)- 2- methylphenoxy)acetic acidIBA
10/2010
1GlycopeptidesIBA
10/2010
1Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
02/2010
1Sodium NitriteIBA
02/2010
1Interleukin-1beta (Interleukin 1 beta)IBA
11/2006
1P-30 composite resin (P 30)IBA
11/2006
1Dinoprostone (PGE2)FDA Link
11/2006
1Nitroblue TetrazoliumIBA
08/2006
1Hydrogen Sulfide (Sulfide, Hydrogen)IBA
08/2006
1propargylglycineIBA
08/2006
1Cystathionine gamma-Lyase (Cysteine Desulfhydrase)IBA
08/2006
1sodium bisulfide (NaHS)IBA
08/2006
1GuanosineIBA
07/2006
1Phosphates (Orthophosphate)IBA
07/2006
1Bacterial DNAIBA
07/2006

Therapy/Procedure

5Therapeutics
07/2017 - 07/2000
4Resuscitation
12/2002 - 06/2000